These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18855743)

  • 21. Efficient in silico assay of inhibitors of hepatitis C Virus RNA-dependent RNA polymerase by structure-based virtual screening and in vitro evaluation.
    Lin YT; Huang KJ; Tseng CK; Chen KJ; Wang HM; Lee JC
    Assay Drug Dev Technol; 2011 Jun; 9(3):290-8. PubMed ID: 21281131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrophobic and charged residues in the C-terminal arm of hepatitis C virus RNA-dependent RNA polymerase regulate initiation and elongation.
    Cherry AL; Dennis CA; Baron A; Eisele LE; Thommes PA; Jaeger J
    J Virol; 2015 Feb; 89(4):2052-63. PubMed ID: 25428878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
    Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
    Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.
    Howe AY; Cheng H; Thompson I; Chunduru SK; Herrmann S; O'Connell J; Agarwal A; Chopra R; Del Vecchio AM
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4103-13. PubMed ID: 16940072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.
    Mo H; Lu L; Pilot-Matias T; Pithawalla R; Mondal R; Masse S; Dekhtyar T; Ng T; Koev G; Stoll V; Stewart KD; Pratt J; Donner P; Rockway T; Maring C; Molla A
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4305-14. PubMed ID: 16189112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
    Xu HT; Hassounah SA; Colby-Germinario SP; Oliveira M; Fogarty C; Quan Y; Han Y; Golubkov O; Ibanescu I; Brenner B; Stranix BR; Wainberg MA
    J Antimicrob Chemother; 2017 Mar; 72(3):727-734. PubMed ID: 28069884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities.
    May MM; Lorengel H; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Biochim Biophys Acta; 2011 Oct; 1814(10):1325-32. PubMed ID: 21621653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.
    Horscroft N; Lai VC; Cheney W; Yao N; Wu JZ; Hong Z; Zhong W
    Antivir Chem Chemother; 2005; 16(1):1-12. PubMed ID: 15739617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors.
    Di Santo R; Fermeglia M; Ferrone M; Paneni MS; Costi R; Artico M; Roux A; Gabriele M; Tardif KD; Siddiqui A; Pricl S
    J Med Chem; 2005 Oct; 48(20):6304-14. PubMed ID: 16190757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479.
    Smith DB; Martin JA; Klumpp K; Baker SJ; Blomgren PA; Devos R; Granycome C; Hang J; Hobbs CJ; Jiang WR; Laxton C; Le Pogam S; Leveque V; Ma H; Maile G; Merrett JH; Pichota A; Sarma K; Smith M; Swallow S; Symons J; Vesey D; Najera I; Cammack N
    Bioorg Med Chem Lett; 2007 May; 17(9):2570-6. PubMed ID: 17317178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymerase.
    Delang L; Froeyen M; Herdewijn P; Neyts J
    Antiviral Res; 2012 Jan; 93(1):30-8. PubMed ID: 22033247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection.
    Sheldon J; Barreiro P; Soriano V
    Expert Opin Investig Drugs; 2007 Aug; 16(8):1171-81. PubMed ID: 17685867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The modeled structure of the RNA dependent RNA polymerase of GBV-C virus suggests a role for motif E in Flaviviridae RNA polymerases.
    Ferron F; Bussetta C; Dutartre H; Canard B
    BMC Bioinformatics; 2005 Oct; 6():255. PubMed ID: 16225688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of optically pure dioxolanes as inhibitors of hepatitis C virus RNA replication.
    Bera S; Malik L; Bhat B; Carroll SS; MacCoss M; Olsen DB; Tomassini JE; Eldrup AB
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4455-8. PubMed ID: 14643345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into structural dynamics of allosteric binding sites in HCV RNA-dependent RNA polymerase.
    Mittal L; Kumari A; Suri C; Bhattacharya S; Asthana S
    J Biomol Struct Dyn; 2020 Apr; 38(6):1612-1625. PubMed ID: 31057089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake RK; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1991-5. PubMed ID: 17276060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Haudecoeur R; Ahmed-Belkacem A; Yi W; Fortuné A; Brillet R; Belle C; Nicolle E; Pallier C; Pawlotsky JM; Boumendjel A
    J Med Chem; 2011 Aug; 54(15):5395-402. PubMed ID: 21699179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives.
    Kozlov MV; Polyakov KM; Ivanov AV; Filippova SE; Kuzyakin AO; Tunitskaya VL; Kochetkov SN
    Biochemistry (Mosc); 2006 Sep; 71(9):1021-6. PubMed ID: 17009957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational predictions suggest that structural similarity in viral polymerases may lead to comparable allosteric binding sites.
    Brown JA; Espiritu MV; Abraham J; Thorpe IF
    Virus Res; 2016 Aug; 222():80-93. PubMed ID: 27262620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.